Your browser doesn't support javascript.
loading
Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection.
Ricciardi, Michael J; Rust, Lauren N; Pedreño-Lopez, Nuria; Yusova, Sofiya; Biswas, Sreya; Webb, Gabriela M; Gonzalez-Nieto, Lucas; Voigt, Thomas B; Louw, Johan J; Laurino, Fernanda D; DiBello, John R; Raué, Hans-Peter; Barber-Axthelm, Aaron M; Chun, Kimberly; Uttke, Samantha; Raphael, Lidiane M S; Yrizarry-Medina, Aaron; Rosen, Brandon C; Agnor, Rebecca; Gao, Lina; Labriola, Caralyn; Axthelm, Michael; Smedley, Jeremy; Julander, Justin G; Bonaldo, Myrna C; Walker, Laura M; Messaoudi, Ilhem; Slifka, Mark K; Burton, Dennis R; Kallas, Esper G; Sacha, Jonah B; Watkins, David I; Burwitz, Benjamin J.
Afiliação
  • Ricciardi MJ; Mabloc LLC, 725 21st St. NW, Suite 301, Washington, DC 20052, USA.
  • Rust LN; George Washington University, 2121 I St. NW, Washington, DC 20052, USA.
  • Pedreño-Lopez N; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Yusova S; George Washington University, 2121 I St. NW, Washington, DC 20052, USA.
  • Biswas S; IrsiCaixa AIDS Research Institute, Ctra. del Canyet SN, Badalona 08916, Barcelona, Spain.
  • Webb GM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Gonzalez-Nieto L; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Voigt TB; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Louw JJ; Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
  • Laurino FD; Mabloc LLC, 725 21st St. NW, Suite 301, Washington, DC 20052, USA.
  • DiBello JR; George Washington University, 2121 I St. NW, Washington, DC 20052, USA.
  • Raué HP; George Washington University, 2121 I St. NW, Washington, DC 20052, USA.
  • Barber-Axthelm AM; Mabloc LLC, 725 21st St. NW, Suite 301, Washington, DC 20052, USA.
  • Chun K; Mabloc LLC, 725 21st St. NW, Suite 301, Washington, DC 20052, USA.
  • Uttke S; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Raphael LMS; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Yrizarry-Medina A; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Rosen BC; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Agnor R; Laboratório de Biologia Molecular de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Gao L; George Washington University, 2121 I St. NW, Washington, DC 20052, USA.
  • Labriola C; Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
  • Axthelm M; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Smedley J; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Julander JG; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Bonaldo MC; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Walker LM; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Messaoudi I; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Slifka MK; Institute for Antiviral Research, Utah State University, Logan, UT 84322, USA.
  • Burton DR; Laboratório de Biologia Molecular de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
  • Kallas EG; Adagio Therapeutics Inc., Waltham, MA 02451, USA.
  • Sacha JB; Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, Lexington, KY 40536, USA.
  • Watkins DI; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
  • Burwitz BJ; Mabloc LLC, 725 21st St. NW, Suite 301, Washington, DC 20052, USA.
Sci Transl Med ; 15(689): eade5795, 2023 03 29.
Article em En | MEDLINE | ID: mdl-36989376
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Febre Amarela / Vacina contra Febre Amarela Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Sci Transl Med Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Febre Amarela / Vacina contra Febre Amarela Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Sci Transl Med Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos